Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Cash & Equivalents (2016 - 2026)

Orthofix Medical has reported Cash & Equivalents over the past 18 years, most recently at $120.3 million for Q1 2026.

  • For the quarter ending Q1 2026, Cash & Equivalents rose 107.54% year-over-year to $120.3 million, compared with a TTM value of $120.3 million through Mar 2026, up 107.54%, and an annual FY2025 reading of $82.0 million, down 1.46% over the prior year.
  • Cash & Equivalents came in at $120.3 million for Q1 2026, up from $82.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $120.3 million in Q1 2026 to a low of $26.4 million in Q2 2024.
  • Median Cash & Equivalents over the past 5 years was $51.7 million (2022), compared with a mean of $55.5 million.
  • The largest YoY upside for Cash & Equivalents was 151.42% in 2024 against a maximum downside of 46.04% in 2024.
  • Over 5 years, Cash & Equivalents stood at $50.7 million in 2022, then crashed by 34.7% to $33.1 million in 2023, then skyrocketed by 151.42% to $83.2 million in 2024, then fell by 1.46% to $82.0 million in 2025, then soared by 46.64% to $120.3 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Cash & Equivalents are $120.3 million (Q1 2026), $82.0 million (Q4 2025), and $62.9 million (Q3 2025).